Panthenol and Pulmonary embolism - a phase IV clinical study of FDA data

Summary:

Pulmonary embolism is reported as a side effect among people who take Panthenol (pantothenic acid (vitamin b5)), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Albuterol Sulfate, and have Nausea and vomiting.

The phase IV clinical study analyzes which people have Pulmonary embolism when taking Panthenol. It is created by eHealthMe based on reports of 2,073 people who have side effects when taking Panthenol from the FDA, and is updated regularly.

What is Panthenol?

Panthenol has active ingredients of pantothenic acid (vitamin b5). eHealthMe is studying from 2,079 Panthenol users. Check the latest studies of Panthenol.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,334 drugs and 2,957 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

On Jul, 25, 2026

2,073 people reported to have side effects when taking Panthenol.
Among them, 65 people (3.14%) have Pulmonary embolism.

Could Panthenol cause Pulmonary embolism?

Among these 65 people:

How long have people been on Panthenol when they have Pulmonary embolism? *

What is the gender of people who have Pulmonary embolism when taking Panthenol? *

female: 23.81 %
male: 76.19 %

What is the age of people who have Pulmonary embolism when taking Panthenol? *

What are other drugs people take besides Panthenol? *

What are other side effects people have besides Pulmonary embolism? *

Dyspnea (difficult or laboured breathing): 41 people, 63.08%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 38 people, 58.46%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 34 people, 52.31%
Diabetes: 34 people, 52.31%
Iron Deficiency: 34 people, 52.31%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 33 people, 50.77%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 33 people, 50.77%
Thrombosis (formation of a blood clot inside a blood vessel): 33 people, 50.77%
Drug Hypersensitivity: 32 people, 49.23%
Sleep Disorder: 32 people, 49.23%

What are the existing conditions these people have? *

Nausea And Vomiting: 38 people, 58.46%
Nausea (feeling of having an urge to vomit): 37 people, 56.92%
Constipation: 37 people, 56.92%
Anaemia (lack of blood): 37 people, 56.92%
Sleep Disorder: 37 people, 56.92%
Diabetes: 37 people, 56.92%
Neuralgia (pain in one or more nerves): 36 people, 55.38%
Blood Uric Acid Increased: 36 people, 55.38%
Blood Phosphorus Increased: 36 people, 55.38%
Bacterial Infection: 36 people, 55.38%

* Approximation only. Some reports may have incomplete information.

Do you take Panthenol and have Pulmonary embolism?

- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Panthenol:

Panthenol (2,079 reports)

Browse all side effects of Panthenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary embolism:

Pulmonary embolism (2,334 drugs)

Browse all the conditions that are associated with Pulmonary embolism:

Pulmonary embolism (2,957 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pantothenic acid (vitamin b5) (the active ingredients of Panthenol) and Panthenol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.